Catalog Number ASKU |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Conjunctivitis (1784); Endophthalmitis (1835); Uveitis (2122); Blurred Vision (2137); Toxic Anterior Segment Syndrome (TASS) (4469); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
|
Event Date 12/17/2021 |
Event Type
Injury
|
Event Description
|
A physician reported that after cataract surgery by using an irrigation/aspiration (i/a) handpiece and phacoemulsification handpiece, a patient experienced severe endophthalmitis or toxic anterior segment syndrome (tass).Additional related information was requested but has not been provided to date.
|
|
Manufacturer Narrative
|
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
|
|
Manufacturer Narrative
|
The phaco handpiece was not returned for evaluation.Specific product identifiers (lot number, batch number, and/or serial number) were not provided and could not be determined at this time.However, all device history records are reviewed prior to product release to ensure the product was manufactured in compliance with the device master record and meets release criteria.A review for complaints reported against this lot/batch/serial number cannot be performed as the lot/batch/serial number is unknown.The product under investigation is not a serviceable device.Therefore, a service record review was not performed.The root cause of the reported events is inconclusive.Manufacturer will continue to monitor data for evidence of adverse trending and take further action, as appropriate.Similar incident/event data was collected for the associated reported events.Quality assurance will continue to perform periodic monitoring for evidence of adverse trending and take further action as appropriate.Refer to the attached file.The manufacturer internal reference number is: (b)(4).
|
|
Manufacturer Narrative
|
The manufacturer internal reference number is: (b)(4).
|
|
Event Description
|
Additional information received indicating that a patient underwent cataract surgery with iol implantation in left eye.After 3 days of surgery the patient experienced with strong inflammation with suspicion of endophthalmitis or tass, conjunctival inflammation: 2+, cells in the anterior chamber: 3+, fibrin in the anterior chamber.Patient was treated with subconjunctival injection: glucocorticoid, other: reinforcement local corticosteroid treatment: antibiotic + corticosteroids 6 times a days; corticosteroid + antibiotic 3 times a days; fluoroquinolones + antibiotics 6 times a days.Medication was effective and patient symptoms were resolved.
|
|
Event Description
|
New information received indicating viscoelastic, balanced salt solution and procedure pak is also a suspect for the adverse event.
|
|
Manufacturer Narrative
|
Additional information has been provided in sections b.5 and d.10.The manufacturer internal reference number is: (b)(4).
|
|
Search Alerts/Recalls
|